Research at Radial

Backed by research.
Driven by care.

Radial clinicians don't just follow the research, they conduct it. From neuromodulation to digital psychiatry, our team actively publishes and participates in clinical trials, ensuring every patient receives care that is grounded in the best available evidence.

Research areas

Narcissism

Movement Disorders

Schizophrenia Spectrum Disorders

Bipolar

Personality Disorders

OCD

PTSD

Anxiety

Depression

Publications

Value
Filter Research
This is some text inside of a div block.

Psychedelic therapy: a primer for primary care clinicians—ketamine

View
Mar-Apr 2024
Viviana D Evans, Alejandro Arenas, Kenneth Shinozuka, Burton J Tabaac, Bryce D Beutler, Kirsten Cherian, Chelsey Fasano, Owen S Muir
Ketamine is already in primary care — but many clinicians lack a framework for its psychiatric applications. This primer covers mechanism, dosing, evidence, and patient selection, helping frontline providers engage knowledgeably with patients seeking this treatment.
Depression
Psychedelic Therapy
This is some text inside of a div block.

Psychedelic Therapy: A Primer for Primary Care Clinicians—Lysergic Acid Diethylamide (LSD)

View
Mar-Apr 2024
Bryce D Beutler, Kenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir
LSD has re-entered serious clinical research after decades of prohibition. This primer gives primary care clinicians a grounded overview of current evidence, safety data, and therapeutic applications of lysergic acid diethylamide.
Depression
Psychedelic Therapy
This is some text inside of a div block.

Psychedelic Therapy: A Primer for Primary Care Clinicians—N, N-Dimethyltryptamine and Ayahuasca

View
Mar-Apr 2024
Kenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, Bryce D Beutler, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir
DMT is among the least understood psychedelics entering therapeutic research — and patient questions are outpacing clinical preparation. This primer offers primary care providers a practical evidence review for informed conversations.
Depression
Psychedelic Therapy
This is some text inside of a div block.

Psychedelic Therapy: A Primer for Primary Care Clinicians—Ibogaine

View
Mar-Apr 2024
Kirsten Cherian, Kenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, Bryce D Beutler, Viviana D Evans, Chelsey Fasano, Owen S Muir
Ibogaine carries both remarkable therapeutic promise and significant safety considerations. This primer helps primary care clinicians understand the evidence, risks, and clinical context for this powerful plant-derived compound.
Depression
Psychedelic Therapy
This is some text inside of a div block.

Psychedelic Therapy: A Primer for Primary Care Clinicians—The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics

View
Mar-Apr 2024
Owen S Muir, Kenneth Shinozuka, Bryce D Beutler, Alejandro Arenas, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Burton J Tabaac
Psychedelic therapy isn't just about individual compounds — it requires a framework for evaluating the whole field. This paper maps the strengths, weaknesses, opportunities, and threats facing psychedelic therapeutics as they move toward mainstream medicine.
Depression
Psychedelic Therapy
This is some text inside of a div block.

Evaluating passive physiological data collection during Spravato treatment

View
Nov 2023
Todd M Solomon, Matus Hajduk, Martin Majernik, Jamileh Jemison, Alexander Deschamps, Jenna Scoggins, Adam Kolar, Miguel Amável Pinheiro, Peter Dubec, Ondrej Skala, Owen Muir, Amanda Tinkelman, Daniel R Karlin, Robert Barrow
Spravato sessions generate rich physiological data — but is anyone capturing it? This study evaluates passive data collection during esketamine treatment, exploring whether wearable monitoring can yield clinically meaningful insights without disrupting care.
Depression
Ketamine Monitoring
This is some text inside of a div block.

Real world efficacy and safety of various accelerated deep TMS protocols for major depression

View
Oct 2023
Yiftach Roth, Colleen A Hanlon, Gaby Pell, Samuel Zibman, Tal Harmelech, Owen S Muir, Carlene MacMillan, Tim Prestley, David C Purselle, Thomas Knightly, Aron Tendler
Not all accelerated Deep TMS protocols are created equal — so which works best? This Phase IV analysis compared multiple accelerated dosing schedules in real-world MDD patients, finding strong and comparable efficacy across 2, 3, 5, and 10 sessions per day.
Depression
Deep TMS
This is some text inside of a div block.

Deep TMS H1 Coil treatment for depression: Results from a large post marketing data analysis

View
Jun 2023
Aron Tendler, Stephan Goerigk, Samuel Zibman, Salomé Ouaknine, Tal Harmelech, Gaby S Pell, Abraham Zangen, Steven A. Harvey, Geoffrey Grammer, Jimmy Stehberg, Oluremi Adefolarin, Owen Muir, Carlene MacMillan, Diana Ghelber, Walter Duffy, Irakli Mania, Zeeshan Faruqui, Faisal Munasifi, Todd Antin, Frank Padberg, Yiftach Roth
What happens when you look at Deep TMS outcomes across more than a thousand patients in real clinical practice? This large post-marketing analysis confirms high response and remission rates for the H1 coil in community settings, with durable effects.
Depression
Deep TMS
This is some text inside of a div block.

Remote monitoring and AI for detecting tardive dyskinesia and improving patient outcomes.

View
Oct 2022
A Sterns, L Larsen, B Grimm, OS Muir
Tardive dyskinesia disrupts lives — and often goes unrecognized until it's advanced. This study examines how remote AI monitoring can detect movement abnormalities earlier, enabling timely clinical response and better long-term patient outcomes.
Movement Disorders
AI / Digital Psychiatry
This is some text inside of a div block.

Remission rates following deep TMS for treatment-resistant OCD

View
Sep-Oct 2022
Roman Gersner, Aron Tendler, Mehmet Kemal Arikan, Ryan Vidrine, Geoff Grammer, Owen Müir, Carlene MacMillan, Rebecca Sinclair, Saad Shakir, David Kent, Raul Rodriguez, Nicholas Evangelidis, Deborah Kim, Tal Harmelech, Yiftach Roth
Treatment-resistant OCD can leave patients cycling through failed medication trials for years. This study reports remission rates following Deep TMS for OCD, demonstrating that neuromodulation offers a meaningful path forward for patients who haven't responded to conventional care.
OCD
Deep TMS
This is some text inside of a div block.

Long-term outcomes of a course of deep TMS for treatment-resistant OCD

View
Jan-Feb 2022
Tal Harmelech, Aron Tendler, Mehmet Kemal Arikan, Hamide Laçin Çetin, Muhammed Taha Esmeray, Reyhan Ilhan, Ryan Vidrine, Owen Muir, Carlene MacMillan, Rebecca Sinclair, Saad Shakir, David Kent, Nicholas Evangelidis, Yiftach Roth
Relief from OCD matters — but so does how long it lasts. This study tracks long-term outcomes following a course of Deep TMS for treatment-resistant OCD, providing some of the most durable follow-up data available for this intervention.
OCD
Deep TMS
This is some text inside of a div block.

Mental health clinicians’ attitudes toward narcissistic personality disorder.

View
Sep 2021
Owen Muir, Jillian N Weinfeld, Danny Ruiz, Dmitry Ostrovsky, Miguel Fiolhais, Carlene MacMillan
Narcissistic personality disorder is one of psychiatry's most stigmatized diagnoses — even among the clinicians treating it. This study surfaces the attitudes and biases mental health professionals hold toward NPD, with implications for training, diagnosis, and therapeutic alliance.
Personality Disorders
Narcissism
Mentalizing-Based Therapy
OCD
Deep TMS
Personality Disorders
Narcissism
Mentalizing-Based Therapy
Personality Disorders
Mentalizing-Based Therapy
Depression
Deep TMS
Depression
Deep TMS
Personality Disorders
Mentalizing-Based Therapy
Personality Disorders
Mentalizing-Based Therapy
Depression
Deep TMS
Movement Disorders
AI / Digital Psychiatry
OCD
Deep TMS
Depression
Deep TMS
Depression
Deep TMS
Depression
Deep TMS
Depression
Ketamine Monitoring
PTSD
Bipolar
TMS
Movement Disorders
AI / Digital Psychiatry
Depression
Accelerated TMS
Movement Disorders
AI / Digital Psychiatry
Depression
Accelerated TMS
OCD
Deep TMS
Depression
Accelerated TMS
Depression
Anxiety
TMS
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Deep TMS
Personality Disorders
Mentalizing-Based Therapy
Depression
Accelerated TMS
Depression
Anxiety
Accelerated TMS
Depression
Accelerated TMS
OCD
Deep TMS
Depression
Deep TMS
Depression
Deep TMS
Depression
Accelerated TMS
Depression
Deep TMS
Depression
Accelerated TMS
Depression
Ketamine Therapy
No items found!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Learn more about our team

Meet the team
Radial logo
Treatments
dropdown arrow
Locations
dropdown arrow
About Radial
dropdown arrow
Legal
dropdown arrow
New & Existing Patients
dropdown arrow
Business Inquiry
dropdown arrow